2021
DOI: 10.1016/j.anai.2021.09.004
|View full text |Cite
|
Sign up to set email alerts
|

Fracture risks in patients with atopic dermatitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 49 publications
0
2
0
Order By: Relevance
“…Systemic treatment of AD impaired the risk of fracture and indicated that While disease-modifying antirheumatic medications (HR = 0.71; 95% CI = 0.53–0.90) and phototherapy (HR = 0.73; 95% CI = 0.56–0.95) treatment decreased the risk of fractures, severe AD was linked to a higher risk of fractures (HR = 1.31, 95% CI = 1.08–1.59) [ 63 ].…”
Section: Osteoporosismentioning
confidence: 99%
“…Systemic treatment of AD impaired the risk of fracture and indicated that While disease-modifying antirheumatic medications (HR = 0.71; 95% CI = 0.53–0.90) and phototherapy (HR = 0.73; 95% CI = 0.56–0.95) treatment decreased the risk of fractures, severe AD was linked to a higher risk of fractures (HR = 1.31, 95% CI = 1.08–1.59) [ 63 ].…”
Section: Osteoporosismentioning
confidence: 99%
“…118 Elderly patients with AD, especially those with longer disease duration, lower vitamin D levels, and systemic inflammation, face higher osteoporosis and fracture risks, recognized by the American Academy of Dermatology. 11,[119][120][121][122][123] Hence, appropriate exercises programs, proactive osteoporosis intervention, and education on fall prevention might be considered essential for elderly patients with AD, whose benefits still require further research for substantiation.…”
Section: Ad and Musculoskeletal Agingmentioning
confidence: 99%
“…The study endpoint was when the study participants were diagnosed with atopic dermatitis. To improve the validity of atopic dermatitis diagnosis, only events consisting of more than three outpatient visits or one inpatient record due to atopic dermatitis were defined as outcome events (14). Each person in the study was followed up from the index date to the date of diagnosis of atopic dermatitis (outcome event), quitting registration from the NHI or on 31 December 2018 (the endpoint of the current study).…”
Section: Study Population Exposure and Outcomesmentioning
confidence: 99%